Christos Karampelias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christos Karampelias has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Olov Andersson
Uppsala University 1 Department of Medical Cell Biology BMC, Husargatan 3, 75123 Uppsala
8 shared publications - Heiko Lickert
Institute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany
5 shared publications - Elisabeth Kemter
Chair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany
4 shared publications Michael Sterr
Institute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany
4 shared publications- Carolyn E. Cesta
Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden
3 shared publications - Eckhard Wolf
Chair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Springer Nature in Diabetologia
- p. 1-22
Pregestational maternal diabetes primes neonatal beta cell dysfunction with structural remodelling, impaired calcium buffering and altered mTORC2–Gαq–PKCα signalling in a pig model
Aims/hypothesis: Offspring of mothers with diabetes are at increased risk of developing type 2 diabetes, and this predisposition is established during fetal life. The aim of this study was to define the functional, morphological and molecular alterations in neonatal pancreatic islets associated with maternal hyperglycaemia, with a particular focus on beta cells, an area that remains poorly understood. Given its similarity to humans in endocrine pancreas development, the pig was used as a translational animal model. Methods: Using genetically diabetic and beta cell reporter pig models, we performed functional assessments of glucose-stimulated insulin secretion in vivo and in situ using fresh pancreatic tissue slices from neonatal piglets born to hyperglycaemic mothers (PHGs) or normoglycaemic mothers (PNGs). Morphological and molecular profiling, including proteomics and single-cell RNA-seq, were performed to elucidate molecular changes reflecting the developmental impact of maternal diabetes on offspring metabolic health, with a particular focus on neonatal beta cells. Results: PHGs were born hyperglycaemic, hyperinsulinaemic and insulin resistant, exhibiting markedly delayed glucose and insulin response curves following oral glucose administration, with more pronounced effects in male piglets. Elevated basal insulin secretion and an almost blunted glucose responsiveness of pancreatic tissue slices were associated with increased insulin and somatostatin content, expansion of beta (+35%) and delta (+47%) cell populations, and organisation into larger islet clusters. Neonatal PHG islets exhibited a molecular profile consistent with intrinsic beta cell dysfunction that partially overlapped with type 2 diabetes (e.g. RBP4 upregulation), together with alterations in glucose sensing (near absence of GLUT2), nutrient metabolism resembling congenital hyperinsulinism ( HADH downregulation), and cytosolic Ca 2 ⁺ homeostasis (near absence of the Ca 2 ⁺ buffer calbindin D28K). In addition to an ATF4-dominated stress signature, a shift towards a distinct PHG beta cell subcluster characterised by low expression of ribosomal genes was observed, with an adaptive early-response-gene-mediated transcriptional reactivity. In contrast to the Gαs–adenylyl cyclase–cAMP–PKA signalling axis that dominated in PNG beta cells, neonatal PHG beta cells displayed distinct alterations in Gαq–PLC–PKCα signalling components, the mTORC2 target PKCα, and CREB1, suggesting a restructured signalling architecture. Conclusions/interpretation: Our findings reveal altered islet modelling with a unique beta cell dysfunction profile that partially overlaps with, but differs from, that of type 2 diabetes. A shift towards a beta cell subcluster exhibiting an adaptive early-response-gene-mediated transcriptional reactivity and an ATF4-associated transcriptional stress signature provides insight into molecular alterations associated with fetal exposure to maternal diabetes and may contribute to the increased risk of metabolic disease in offspring.
- 6 November 2026
- Published by Springer Nature in Diabetologia
- p. 1-22
Open AccessPregestational maternal diabetes primes neonatal beta cell dysfunction with structural remodelling, impaired calcium buffering and altered mTORC2–Gαq–PKCα signalling in a pig model
Aims/hypothesis: Offspring of mothers with diabetes are at increased risk of developing type 2 diabetes, and this predisposition is established during fetal life. The aim of this study was to define the functional, morphological and molecular alterations in neonatal pancreatic islets associated with maternal hyperglycaemia, with a particular focus on beta cells, an area that remains poorly understood. Given its similarity to humans in endocrine pancreas development, the pig was used as a translational animal model. Methods: Using genetically diabetic and beta cell reporter pig models, we performed functional assessments of glucose-stimulated insulin secretion in vivo and in situ using fresh pancreatic tissue slices from neonatal piglets born to hyperglycaemic mothers (PHGs) or normoglycaemic mothers (PNGs). Morphological and molecular profiling, including proteomics and single-cell RNA-seq, were performed to elucidate molecular changes reflecting the developmental impact of maternal diabetes on offspring metabolic health, with a particular focus on neonatal beta cells. Results: PHGs were born hyperglycaemic, hyperinsulinaemic and insulin resistant, exhibiting markedly delayed glucose and insulin response curves following oral glucose administration, with more pronounced effects in male piglets. Elevated basal insulin secretion and an almost blunted glucose responsiveness of pancreatic tissue slices were associated with increased insulin and somatostatin content, expansion of beta (+35%) and delta (+47%) cell populations, and organisation into larger islet clusters. Neonatal PHG islets exhibited a molecular profile consistent with intrinsic beta cell dysfunction that partially overlapped with type 2 diabetes (e.g. RBP4 upregulation), together with alterations in glucose sensing (near absence of GLUT2), nutrient metabolism resembling congenital hyperinsulinism ( HADH downregulation), and cytosolic Ca 2 ⁺ homeostasis (near absence of the Ca 2 ⁺ buffer calbindin D28K). In addition to an ATF4-dominated stress signature, a shift towards a distinct PHG beta cell subcluster characterised by low expression of ribosomal genes was observed, with an adaptive early-response-gene-mediated transcriptional reactivity. In contrast to the Gαs–adenylyl cyclase–cAMP–PKA signalling axis that dominated in PNG beta cells, neonatal PHG beta cells displayed distinct alterations in Gαq–PLC–PKCα signalling components, the mTORC2 target PKCα, and CREB1, suggesting a restructured signalling architecture. Conclusions/interpretation: Our findings reveal altered islet modelling with a unique beta cell dysfunction profile that partially overlaps with, but differs from, that of type 2 diabetes. A shift towards a beta cell subcluster exhibiting an adaptive early-response-gene-mediated transcriptional reactivity and an ATF4-associated transcriptional stress signature provides insight into molecular alterations associated with fetal exposure to maternal diabetes and may contribute to the increased risk of metabolic disease in offspring.
- Open Access
- 20 October 2026
- Published by Springer Nature in Diabetologia
- p. 1-16
CCKBR signalling controls human definitive endoderm specification and pancreatic lineage differentiation
Aims/hypothesis: Paracrine signalling by hormone-producing endocrine cells potentially influences pancreatic development, but this feedback regulation remains poorly understood. Here, we investigated the roles of gastrin (GAST), cholecystokinin (CCK) and their receptor cholecystokinin B receptor (CCKBR) during human pancreatic development. Methods: Human iPSCs were differentiated stepwise into definitive endoderm and then the pancreatic endocrine lineage. To assess CCKBR function, CRISPR/Cas9 was used to generate CCKBR-knockout iPSC lines. We profiled transcriptional states by bulk and single-cell RNA-seq with computational analyses, and complemented these with biochemical assays, flow cytometry (FACS) and confocal microscopy. Results: CCKBR expression peaked during definitive endoderm formation and progressively declined during differentiation, remaining detectable in pancreatic progenitors but largely absent from the endocrine lineage. By contrast, GAST and CCK were expressed only transiently during pancreatic progenitor and endocrine lineage formation. Pharmacological activation/inhibition and genetic knockout implicated CCKBR signalling during definitive endoderm formation. Consistently, bulk RNA-seq indicated that CCKBR deletion triggered ectodermal- and mesodermal-associated transcriptional programs and diminished pancreatic lineage specification. During pancreatic induction and lineage formation, sustained CCKBR activation with GAST or CCK attenuated endocrinogenesis and promoted epithelial structure formation. Further analysis revealed the emergence of a pancreatic ductal-like cell formation under prolonged CCKBR stimulation. Conclusions/interpretation: This study provides mechanistic evidence that the GAST/CCK–CCKBR axis is functionally important during human endoderm and pancreas development. This pathway is repeatedly required during in vitro pluripotent stem cell differentiation, regulating germ-layer formation as well as ductal vs endocrine fate decisions. These findings support the optimisation of pancreatic differentiation protocols and inform future studies on whether this axis contributes to human pancreas development and disease.
- 20 October 2026
- Published by Springer Nature in Diabetologia
- p. 1-16
Open AccessCCKBR signalling controls human definitive endoderm specification and pancreatic lineage differentiation
Aims/hypothesis: Paracrine signalling by hormone-producing endocrine cells potentially influences pancreatic development, but this feedback regulation remains poorly understood. Here, we investigated the roles of gastrin (GAST), cholecystokinin (CCK) and their receptor cholecystokinin B receptor (CCKBR) during human pancreatic development. Methods: Human iPSCs were differentiated stepwise into definitive endoderm and then the pancreatic endocrine lineage. To assess CCKBR function, CRISPR/Cas9 was used to generate CCKBR-knockout iPSC lines. We profiled transcriptional states by bulk and single-cell RNA-seq with computational analyses, and complemented these with biochemical assays, flow cytometry (FACS) and confocal microscopy. Results: CCKBR expression peaked during definitive endoderm formation and progressively declined during differentiation, remaining detectable in pancreatic progenitors but largely absent from the endocrine lineage. By contrast, GAST and CCK were expressed only transiently during pancreatic progenitor and endocrine lineage formation. Pharmacological activation/inhibition and genetic knockout implicated CCKBR signalling during definitive endoderm formation. Consistently, bulk RNA-seq indicated that CCKBR deletion triggered ectodermal- and mesodermal-associated transcriptional programs and diminished pancreatic lineage specification. During pancreatic induction and lineage formation, sustained CCKBR activation with GAST or CCK attenuated endocrinogenesis and promoted epithelial structure formation. Further analysis revealed the emergence of a pancreatic ductal-like cell formation under prolonged CCKBR stimulation. Conclusions/interpretation: This study provides mechanistic evidence that the GAST/CCK–CCKBR axis is functionally important during human endoderm and pancreas development. This pathway is repeatedly required during in vitro pluripotent stem cell differentiation, regulating germ-layer formation as well as ductal vs endocrine fate decisions. These findings support the optimisation of pancreatic differentiation protocols and inform future studies on whether this axis contributes to human pancreas development and disease.
- Open Access
Integrated histological and proteomic mapping of pancreatic adaptations during porcine pregnancy
Pregnancy is a period of extensive metabolic rewiring. Insulin secreting β-cells respond to the metabolic challenges of pregnancy by increasing their mass and size and by altering secretory patterns to maintain glucose homeostasis. If glucose metabolism is not tightly controlled, gestational diabetes may develop. Most studies on β-cell adaptation during pregnancy are derived from rodent models, making translation to the vastly different human gestational setting challenging. In this work, we performed an extensive characterization of pancreatic adaptations throughout porcine pregnancy. Pigs have a long gestational period (114 days) and share a similar size and metabolism to humans, making them an ideal model to bridge the knowledge gap between rodents and humans. By analyzing pancreatic samples from early and late gestational ages, we captured the full trajectory of endocrine remodeling. We observed pregnancy-driven remodeling of endocrine cell types, marked by preferential expansion of pancreatic polypeptide-secreting cells. Proteomic characterization of the pancreas from early and late gestation showed a downregulation of SLC20A2 and ZCCHC7, identifying new protein targets involved in physiological endocrine cell adaptation. Overall, our comprehensive characterization of pancreatic adaptations in the pig model helps bridge the translational gap between rodents and humans and highlights previously unrecognized proteins with therapeutic potential for gestational diabetes.
Open AccessIntegrated histological and proteomic mapping of pancreatic adaptations during porcine pregnancy
Pregnancy is a period of extensive metabolic rewiring. Insulin secreting β-cells respond to the metabolic challenges of pregnancy by increasing their mass and size and by altering secretory patterns to maintain glucose homeostasis. If glucose metabolism is not tightly controlled, gestational diabetes may develop. Most studies on β-cell adaptation during pregnancy are derived from rodent models, making translation to the vastly different human gestational setting challenging. In this work, we performed an extensive characterization of pancreatic adaptations throughout porcine pregnancy. Pigs have a long gestational period (114 days) and share a similar size and metabolism to humans, making them an ideal model to bridge the knowledge gap between rodents and humans. By analyzing pancreatic samples from early and late gestational ages, we captured the full trajectory of endocrine remodeling. We observed pregnancy-driven remodeling of endocrine cell types, marked by preferential expansion of pancreatic polypeptide-secreting cells. Proteomic characterization of the pancreas from early and late gestation showed a downregulation of SLC20A2 and ZCCHC7, identifying new protein targets involved in physiological endocrine cell adaptation. Overall, our comprehensive characterization of pancreatic adaptations in the pig model helps bridge the translational gap between rodents and humans and highlights previously unrecognized proteins with therapeutic potential for gestational diabetes.
- Open Access
- 18 May 2026
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 37 (11) , 1047-1062
From architecture to function: mechanisms shaping pancreatic islet morphogenesis
- 18 May 2026
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 37 (11) , 1047-1062
Open AccessFrom architecture to function: mechanisms shaping pancreatic islet morphogenesis
- Open Access
- 4 November 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (12) , 3657-3688
Benchmarking porcine pancreatic ductal organoids for drug screening applications
Primary human pancreatic ductal organoids (HPDO) have emerged as a model to study pancreas biology and model disease like pancreatitis and pancreatic cancer. Yet, donor material availability, genetic variability and a lack of extensive benchmarking to healthy and disease pancreas limits the range of applications. To address this gap, we established porcine pancreatic ductal organoids (PPDO) as a system from a reliable, genetically defined and easily obtainable source to model pancreatic ductal/progenitor biology. We benchmarked PPDO to HPDO and primary porcine pancreas using single-cell RNA sequencing (scRNA-Seq). We observed no overt phenotypic differences in PPDO derived from distinct developmental stages using extensive proteomics profiling, with a WNT/basal cell signaling enriched population characterizing PPDO. PPDO exhibited differentiation potential towards mature ductal cells and limited potential towards endocrine lineages. We used PPDO as a chemical screening platform to assess the safety of FDA-approved drugs and showed conserved toxicity of statins and α-adrenergic receptor inhibitors between PPDO and HPDO cultures. Overall, our results highlight the PPDO as a model for mammalian duct/progenitor applications.
- 4 November 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (12) , 3657-3688
Open AccessBenchmarking porcine pancreatic ductal organoids for drug screening applications
Primary human pancreatic ductal organoids (HPDO) have emerged as a model to study pancreas biology and model disease like pancreatitis and pancreatic cancer. Yet, donor material availability, genetic variability and a lack of extensive benchmarking to healthy and disease pancreas limits the range of applications. To address this gap, we established porcine pancreatic ductal organoids (PPDO) as a system from a reliable, genetically defined and easily obtainable source to model pancreatic ductal/progenitor biology. We benchmarked PPDO to HPDO and primary porcine pancreas using single-cell RNA sequencing (scRNA-Seq). We observed no overt phenotypic differences in PPDO derived from distinct developmental stages using extensive proteomics profiling, with a WNT/basal cell signaling enriched population characterizing PPDO. PPDO exhibited differentiation potential towards mature ductal cells and limited potential towards endocrine lineages. We used PPDO as a chemical screening platform to assess the safety of FDA-approved drugs and showed conserved toxicity of statins and α-adrenergic receptor inhibitors between PPDO and HPDO cultures. Overall, our results highlight the PPDO as a model for mammalian duct/progenitor applications.
- Open Access
Benchmarking porcine pancreatic ductal organoids for drug screening applications
Summary: Primary human pancreatic ductal organoids (HPDO) have emerged as a model to study pancreas biology and disease. Yet, donor material availability, and a lack of extensive benchmarking limits the range of applications. To address this gap, we established porcine pancreatic ductal organoids (PPDO) as a system from an easily obtainable source to model pancreatic ductal/progenitor biology. We benchmarked PPDO to HPDO and primary porcine pancreas using single-cell RNA sequencing (scRNA-Seq). We observed no overt phenotypic differences in PPDO derived from distinct developmental stages, with a WNT signaling enriched population characterizing PPDO. PPDO exhibited differentiation potential towards mature ductal cells and limited potential towards endocrine lineages. We used PPDO as a platform to assess the safety of FDA-approved drugs and showed conserved toxicity of statins and α-adrenergic receptor inhibitors between PPDO and HPDO cultures. Overall, our results highlight the PPDO as a model for mammalian duct/progenitor applications.
Open AccessBenchmarking porcine pancreatic ductal organoids for drug screening applications
Summary: Primary human pancreatic ductal organoids (HPDO) have emerged as a model to study pancreas biology and disease. Yet, donor material availability, and a lack of extensive benchmarking limits the range of applications. To address this gap, we established porcine pancreatic ductal organoids (PPDO) as a system from an easily obtainable source to model pancreatic ductal/progenitor biology. We benchmarked PPDO to HPDO and primary porcine pancreas using single-cell RNA sequencing (scRNA-Seq). We observed no overt phenotypic differences in PPDO derived from distinct developmental stages, with a WNT signaling enriched population characterizing PPDO. PPDO exhibited differentiation potential towards mature ductal cells and limited potential towards endocrine lineages. We used PPDO as a platform to assess the safety of FDA-approved drugs and showed conserved toxicity of statins and α-adrenergic receptor inhibitors between PPDO and HPDO cultures. Overall, our results highlight the PPDO as a model for mammalian duct/progenitor applications.
- 29 January 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21 (6) , 807-818
Mechanistic insights and approaches for beta cell regeneration
Diabetes is characterized by variable loss of insulin-producing beta cells, and new regenerative approaches to increasing the functional beta cell mass of patients hold promise for reversing disease progression. In this Review, we summarize recent chemical biology breakthroughs advancing our knowledge of beta cell regeneration. We present current chemical-based tools, sensors and mechanistic insights into pathways that can be targeted to enhance beta cell regeneration in model organisms. We group the pathways according to the cellular processes they affect, that is, proliferation, conversion of other mature cell types to beta cells and beta cell differentiation from progenitor-like populations. We also suggest assays for assessing the functionality of the regenerated beta cells. Although regeneration processes differ between animal models, such as zebrafish, mice and pigs, regenerative mechanisms identified in any one animal model may be translatable to humans. Overall, chemical biology-based approaches in beta cell regeneration give hope that specific molecular pathways can be targeted to enhance beta cell regeneration.
- 29 January 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21 (6) , 807-818
Mechanistic insights and approaches for beta cell regeneration
Diabetes is characterized by variable loss of insulin-producing beta cells, and new regenerative approaches to increasing the functional beta cell mass of patients hold promise for reversing disease progression. In this Review, we summarize recent chemical biology breakthroughs advancing our knowledge of beta cell regeneration. We present current chemical-based tools, sensors and mechanistic insights into pathways that can be targeted to enhance beta cell regeneration in model organisms. We group the pathways according to the cellular processes they affect, that is, proliferation, conversion of other mature cell types to beta cells and beta cell differentiation from progenitor-like populations. We also suggest assays for assessing the functionality of the regenerated beta cells. Although regeneration processes differ between animal models, such as zebrafish, mice and pigs, regenerative mechanisms identified in any one animal model may be translatable to humans. Overall, chemical biology-based approaches in beta cell regeneration give hope that specific molecular pathways can be targeted to enhance beta cell regeneration.
- Open Access
- 19 August 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (11) , e202402771
Examining the liver–pancreas crosstalk reveals a role for the molybdenum cofactor in β-cell regeneration
Regeneration of insulin-producing β-cells is an alternative avenue to manage diabetes, and it is crucial to unravel this process in vivo during physiological responses to the lack of β-cells. Here, we aimed to characterize how hepatocytes can contribute to β-cell regeneration, either directly or indirectly via secreted proteins or metabolites, in a zebrafish model of β-cell loss. Using lineage tracing, we show that hepatocytes do not directly convert into β-cells even under extreme β-cell ablation conditions. A transcriptomic analysis of isolated hepatocytes after β-cell ablation displayed altered lipid- and glucose-related processes. Based on the transcriptomics, we performed a genetic screen that uncovers a potential role of the molybdenum cofactor (Moco) biosynthetic pathway in β-cell regeneration and glucose metabolism in zebrafish. Consistently, molybdenum cofactor synthesis 2 (Mocs2) haploinsufficiency in mice indicated dysregulated glucose metabolism and liver function. Together, our study sheds light on the liver–pancreas crosstalk and suggests that the molybdenum cofactor biosynthesis pathway should be further studied in relation to glucose metabolism and diabetes.
- 19 August 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (11) , e202402771
Open AccessExamining the liver–pancreas crosstalk reveals a role for the molybdenum cofactor in β-cell regeneration
Regeneration of insulin-producing β-cells is an alternative avenue to manage diabetes, and it is crucial to unravel this process in vivo during physiological responses to the lack of β-cells. Here, we aimed to characterize how hepatocytes can contribute to β-cell regeneration, either directly or indirectly via secreted proteins or metabolites, in a zebrafish model of β-cell loss. Using lineage tracing, we show that hepatocytes do not directly convert into β-cells even under extreme β-cell ablation conditions. A transcriptomic analysis of isolated hepatocytes after β-cell ablation displayed altered lipid- and glucose-related processes. Based on the transcriptomics, we performed a genetic screen that uncovers a potential role of the molybdenum cofactor (Moco) biosynthetic pathway in β-cell regeneration and glucose metabolism in zebrafish. Consistently, molybdenum cofactor synthesis 2 (Mocs2) haploinsufficiency in mice indicated dysregulated glucose metabolism and liver function. Together, our study sheds light on the liver–pancreas crosstalk and suggests that the molybdenum cofactor biosynthesis pathway should be further studied in relation to glucose metabolism and diabetes.
- Open Access
- 1 July 2024
- Published by Taylor & Francis in Studies in Higher Education
- Vol. 50 (6) , 1138-1150
Behind the scenes of doctoral success: a mixed methods approach to exploring PhD supervision courses in Swedish higher education institutions
- 1 July 2024
- Published by Taylor & Francis in Studies in Higher Education
- Vol. 50 (6) , 1138-1150
Open AccessBehind the scenes of doctoral success: a mixed methods approach to exploring PhD supervision courses in Swedish higher education institutions
- Open Access
Characterization of liver-pancreas crosstalk following β-cell loss reveals a role for the molybdenum cofactor in β-cell regeneration
Regeneration of insulin-producing β-cells is an alternative avenue to manage diabetes, and it is crucial to unravel this process in vivo during physiological responses to the lack of β-cells. Here, we aimed to characterize how hepatocytes can contribute to β-cell regeneration in a zebrafish model of β-cell ablation. Using lineage-tracing, we show that hepatocytes do not directly convert into β-cells even under extreme β-cell ablation conditions. A transcriptomics analysis of isolated hepatocytes following β-cell ablation displayed altered lipid- and glucose-related processes. Based on the transcriptomics, we performed a genetic screen that uncovers a potential role for the molybdenum cofactor (Moco) biosynthetic pathway in β-cell regeneration and glucose metabolism in zebrafish. Consistently, Mocs2 haploinsufficiency in mice indicated dysregulated glucose metabolism and liver function. Together, our study sheds light on the liver-pancreas crosstalk and suggests that the molybdenum cofactor biosynthesis pathway should be further studied in relation to glucose metabolism and diabetes.
Open AccessCharacterization of liver-pancreas crosstalk following β-cell loss reveals a role for the molybdenum cofactor in β-cell regeneration
Regeneration of insulin-producing β-cells is an alternative avenue to manage diabetes, and it is crucial to unravel this process in vivo during physiological responses to the lack of β-cells. Here, we aimed to characterize how hepatocytes can contribute to β-cell regeneration in a zebrafish model of β-cell ablation. Using lineage-tracing, we show that hepatocytes do not directly convert into β-cells even under extreme β-cell ablation conditions. A transcriptomics analysis of isolated hepatocytes following β-cell ablation displayed altered lipid- and glucose-related processes. Based on the transcriptomics, we performed a genetic screen that uncovers a potential role for the molybdenum cofactor (Moco) biosynthetic pathway in β-cell regeneration and glucose metabolism in zebrafish. Consistently, Mocs2 haploinsufficiency in mice indicated dysregulated glucose metabolism and liver function. Together, our study sheds light on the liver-pancreas crosstalk and suggests that the molybdenum cofactor biosynthesis pathway should be further studied in relation to glucose metabolism and diabetes.